The results of this study showed that median progression-free survival was significantly improved with talazoparib treatment, and interim analysis of overall survival also showed a positive trend.
← all excerpts
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer.
1
—
—